Homepage

RxSight, Inc.

RXST NASDAQ Categories PDF
Healthcare · Medical - Devices
Aliso Viejo, CA 92656, United States IPO 2021 rxsight.com Updated Jun 27, 1:41am
Price
$5.36
Market Cap
$221.9M
Employees
498
Beta
1.13
Avg Volume
818,050
CEO
Ronald Kurtz
Business Description

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.

Business History
Price Overview
Last updated: Jun 27, 2026 8:59am (just now)
$5.36
+0.23 (+4.48%)
Day Range
$4.95 – $5.45
52-Week Range
$4.48 – $13.65
50-Day MA
$5.90
200-Day MA
$8.26
Volume
3,467,909.00
Analyst Price Targets
Low $9.00
Consensus $10.33
High $11.00
(22 analysts)
Share Structure
Outstanding 41,396,609.00
Float 39,089,990.00
Free Float 94.4%
High free float — 94.4% of shares trade freely, ~5.6% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Jun 27, 2026 1:41am (7h ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jun 21, 2026 7:54pm (5d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-5.64
Stock Price: $5.36
EPS (Diluted): -0.95
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
1.56
Stock Price: $5.36
Total Equity: $275.68M
Shares: 41,175,725
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-4.98
Market Cap: $221.89M
Total Debt: $9.88M
Cash: $19.95M
EBITDA: -$38.84M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$420.1M
Market Cap: $221.89M
Total Debt: $9.88M
Cash: $19.95M
P/S Ratio (Price per dollar of revenue)
API
Stock Price / Revenue Per Share
3.19
Stock Price: $5.36
Revenue: $134.48M
Shares: 41,175,725
EV/Sales (Total value vs revenue — works when P/E can't)
API
3.12
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
76.6%
Gross Profit: $103.01M
Revenue: $134.48M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-35.8%
Operating Income: -$48.19M
Revenue: $134.48M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-29.0%
Net Income: -$38.94M
Revenue: $134.48M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-17.0%
Net Income: -$38.94M
Total Equity: $275.68M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-19.9%
Operating Income: -$48.19M
Tax Rate: -0.2%
Equity: $275.68M
Total Debt: $9.88M
Cash: $19.95M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
10.95
Current Assets: $287.46M
Current Liabilities: $26.25M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.04
Short-Term Debt: $0.00
Long-Term Debt: $9.88M
Total Debt: $9.88M
Total Equity: $275.68M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$3.27
Revenue: $134.48M
Shares: 41,175,725
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$6.70
Total Equity: $275.68M
Shares: 41,175,725
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-0.47
Operating CF: -$15.51M
CapEx: -$3.83M
Shares: 41,175,725
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $5.36
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: -$38.94M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares RXST against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 21, 2026 7:54pm (5d ago)
Metric 2021 2022 2023 2024 2025
Revenue $22.6M $49.0M $89.1M $139.9M $134.5M
Cost of Revenue $18.1M $27.7M $35.3M $41.0M $31.5M
Gross Profit $4.5M $21.3M $53.8M $98.9M $103.0M
Operating Expenses $57.3M $84.6M $103.9M $135.8M $151.2M
Operating Income -$52.8M -$63.3M -$50.1M -$36.9M -$48.2M
Net Income -$48.7M -$66.8M -$48.6M -$27.5M -$38.9M
EBITDA -$41.0M -$57.8M -$41.0M -$23.8M -$38.8M
EPS $-1.78 $-2.41 $-1.41 $-0.71 $-0.95
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jun 21, 2026 7:54pm (5d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $24.4M $11.8M $9.7M $16.7M $19.9M
Total Current Assets $176.3M $134.6M $168.4M $293.8M $287.5M
Total Assets $192.7M $150.2M $182.6M $318.6M $311.8M
Current Liabilities $11.1M $17.2M $20.9M $25.9M $26.3M
Long-Term Debt $39.8M $40.2M $0 $0 $9.9M
Total Liabilities $54.5M $60.3M $22.2M $37.3M $36.1M
Total Equity $138.2M $89.9M $160.4M $281.2M $275.7M
Retained Earnings -$479.3M -$546.0M -$594.6M -$622.1M -$661.0M
Cash Flow (Annual)
Last updated: Jun 21, 2026 7:54pm (5d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$44.7M -$58.9M -$41.6M -$16.9M -$15.5M
Capital Expenditure -$1.9M -$2.4M -$4.8M -$5.4M -$3.8M
Free Cash Flow -$46.6M -$61.2M -$46.4M -$22.4M -$19.3M
Acquisitions (net) $80.0M -$42.3M $17.3M $0 $0
Debt Repayment
Dividends Paid
Stock Buybacks $0 $0 $0 $0 $0
Net Change in Cash $10.7M -$12.6M -$2.2M $7.1M $3.2M
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 1:41am (7h ago)
Metric 2025 2026 2027 2028
Revenue $131.6M
$128.7M – $134.3M
$129.2M
$127.9M – $130.1M
$142.3M
$139.0M – $145.3M
$155.0M
$155.0M – $155.0M
EBITDA -$76.8M
-$78.4M – -$75.1M
-$75.5M
-$76.0M – -$74.7M
-$83.1M
-$84.8M – -$81.1M
-$90.5M
-$90.5M – -$90.5M
Net Income -$42.6M
-$46.4M – -$38.9M
-$59.0M
-$63.7M – -$52.2M
-$54.7M
-$60.5M – -$45.1M
-$50.9M
-$55.6M – -$41.2M
EPS
Growth Trends (YoY %)
Last updated: Jun 21, 2026 7:54pm (5d ago)
Metric 2022 2023 2024 2025
Revenue Growth +116.9% +81.8% +57.1% -3.9%
Gross Profit Growth +372.2% +152.1% +84.0% +4.1%
Operating Income Growth -19.9% +20.9% +26.4% -30.7%
Net Income Growth -37.1% +27.2% +43.5% -41.8%
EBITDA Growth -40.9% +29.0% +42.1% -63.5%
Insider Trading (Recent)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-06-17 Warner Robert Keith A-Award 37,037.00 $0.00 $0
2026-06-17 PALMISANO ROBERT J A-Award 37,037.00 $0.00 $0
2026-06-17 Maniar Shweta A-Award 37,037.00 $0.00 $0
2026-06-17 Fountain Tamara A-Award 37,037.00 $0.00 $0
2026-06-17 LINK WILLIAM J PHD A-Award 37,037.00 $0.00 $0
2026-06-17 Corley Jesse Anderson A-Award 37,037.00 $0.00 $0
2026-06-17 COHEN RAYMOND W A-Award 30,864.00 $0.00 $0
2026-06-17 Tammenoms Bakker Juliet A-Award 37,037.00 $0.00 $0
2026-06-17 Andrews Julie A-Award 37,037.00 $0.00 $0
2026-04-17 Goldshleger Ilya M-Exempt 12,489.00 $4.13 $51,580
2026-04-17 Goldshleger Ilya M-Exempt 12,489.00 $4.13 $51,580
2026-02-28 Wilterding Mark M-Exempt 20,441.00 $0.00 $0
2026-02-28 Wilterding Mark M-Exempt 20,441.00 $0.00 $0
2026-02-28 Wilterding Mark F-InKind 8,068.00 $7.61 $61,397
2026-02-27 Gaines Scott A-Award 32,218.00 $0.00 $0
2026-02-28 Gaines Scott M-Exempt 6,261.00 $0.00 $0
2026-02-28 Gaines Scott F-InKind 2,580.00 $7.61 $19,634
2026-02-28 Gaines Scott M-Exempt 1,657.00 $0.00 $0
2026-02-28 Gaines Scott M-Exempt 1,250.00 $0.00 $0
2026-02-28 Gaines Scott M-Exempt 1,500.00 $0.00 $0
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for RXST — it's generated by the pipeline (market-narrative step).
Community AI Feedback
No community reviews yet for RXST. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30